Herpes Zoster Onset 9 Years After First Varicella Zoster Vaccination in an 11-year-old Child - A Case Report
- PMID: 30887925
- PMCID: PMC7040500
- DOI: 10.2174/1573396315666190318163927
Herpes Zoster Onset 9 Years After First Varicella Zoster Vaccination in an 11-year-old Child - A Case Report
Abstract
Background: Herpes zoster (HZ) tends to affect the elderly population and immunocompromised younger patients. However, HZ cases in healthy children have also been reported.
Objective: This paper is a reminder to physicians, that Herpes Zoster can still be present in children, even in the era after the development of the varicella vaccine and its introduction in the national immunization programs globally.
Methods: We present the case of an immunocompetent 11-year old vaccinated male patient, who developed a HZ infection. The child had received two doses of the VZV vaccination (Varivax®), nine years (first dose) and six years (second dose) prior to the infection.
Results: Together with the case presentation, we summarize in this report the most recent published data, concerning the HZ prevalence in healthy varicella zoster vaccinated children.
Conclusion: Vaccinated pediatric patients are not completely free of risk concerning HZ. Physicians, especially pediatricians and dermatologists, should be alert in order to recognize and treat HZ early, so as to avoid further complications.
Keywords: Herpes zoster; children; complications; immunocompetent; vaccination; varicella..
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Herpes zoster in a 2-year-old vaccinated against varicella.Dermatol Online J. 2014 Jan 15;20(1):21259. Dermatol Online J. 2014. PMID: 24456962
-
Pediatric vaccine-strain herpes zoster: a case series.Pediatr Dermatol. 2017 Nov;34(6):665-667. doi: 10.1111/pde.13265. Epub 2017 Sep 25. Pediatr Dermatol. 2017. PMID: 28944968
-
Herpes zoster and meningitis resulting from reactivation of varicella vaccine virus in an immunocompetent child.Ann Emerg Med. 2009 Jun;53(6):792-5. doi: 10.1016/j.annemergmed.2008.10.023. Epub 2008 Nov 22. Ann Emerg Med. 2009. PMID: 19028409
-
Antiviral therapy for varicella and herpes zoster.Semin Pediatr Infect Dis. 2002 Jan;13(1):12-21. doi: 10.1053/spid.2002.29753. Semin Pediatr Infect Dis. 2002. PMID: 12118839 Review.
-
Varicella-zoster virus infections in the immunocompromised host. Natural history and treatment.Scand J Infect Dis Suppl. 1991;80:69-74. Scand J Infect Dis Suppl. 1991. PMID: 1666447 Review.
Cited by
-
Herpes Zoster in an Immunocompetent Child without a History of Varicella.Pediatr Rep. 2021 Apr 1;13(2):162-167. doi: 10.3390/pediatric13020022. Pediatr Rep. 2021. PMID: 33916031 Free PMC article.
References
-
- Weinmann S., Chun C., Schmid D.S., et al. Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005-2009. J. Infect. Dis. 2013;208(11):1859–1868. - PubMed
-
- Civen R., Marin M., Zhang J., et al. Update on incidence of herpes zoster among children and adolescents after implementation of varicella vaccination, antelope valley, CA, 2000 to 2010. Pediatr. Infect. Dis. J. 2016;35(10):1132–1136. - PubMed
-
- Wutzler P., Casabona G., Cnops J., Akpo E.I.H., Safadi M.A.P. Herpes zoster in the context of varicella vaccination - An equation with several variables. Vaccine. 2018;36(46):7072–7082. - PubMed
-
- Civen R., Chaves S.S., Jumaan A., et al. The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination. Pediatr. Infect. Dis. J. 2009;28(11):954–959. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical